ASHLEY CHAN: Open Payments
NPI 1457764938 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 47 payments from 15 companies in 2025. Trend: 2023 $835 · 2024 $1,084 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $196 |
| ABBVIE INC. | 7 | $137 |
| PFIZER INC. | 5 | $100 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| Exact Sciences Corporation | 4 | $87 |
| Lilly USA, LLC | 4 | $69 |
| ViiV Healthcare Company | 2 | $43 |
| Dexcom, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| Theratechnologies Inc. | 1 | $25 |
Products named: SHINGRIX, QULIPTA, PREVNAR 20, FARXIGA, MOUNJARO, AIRSUPRA, The Cologuard Plus Collection Kit, BREZTRI.
Industry payments across LA — which companies pay providers there.
